Edwards Lifesciences Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Edwards Lifesciences (EW) PT Raised to $260 at RBC Capital
October 24, 2019 6:25 AM EDTRBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $260.00 (from $250.00) while maintaining an Outperform rating.
US TAVR growth of +30%"We now model 2019 and 2020 revenues of $4.32B (previously $4.22B) and $4.74B (previously $4.64B), respectively. Moving to the... MoreEdwards Lifesciences (EW) Tops Q3 EPS by 19c, Updates FY Guidance
October 23, 2019 4:20 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $1.41, $0.19 better than the analyst estimate of $1.22. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.50-$5.65, versus the consensus of $5.34.... More
